Getting an NHS study approved
In the UK, the NHS plays a central role in the governance and ethical review of research involving human participants. Getting through that process efficiently requires preparation: knowing what documentation is needed, having it ready in the right format, and understanding what the committees reviewing your work are actually looking for.
The stakes of getting this right the first time are higher than they might seem. Research Ethics Committee review carries a statutory maximum of 60 days, but the HRA's own published performance data shows well-prepared applications routinely clear review in under 30 days, commercially sponsored studies averaging 29 days and non-commercial studies averaging 28 in the most recent reporting year. The gap between that fast path and the slow one isn't luck. It's almost entirely down to how complete and internally consistent the submission was the first time around, since every round of a request for further information pauses the clock and adds weeks.
Here are the core elements you will need to have in order before a study can be approved.
Research Ethics Committee (REC) review
A REC brings together lay members and people with experience in clinical research and regulation. Their job is to assess whether your study is ethical, whether participants are adequately protected, and whether the risks are proportionate to the potential benefit. Your submission needs to demonstrate all three clearly.
Informed consent documents
REC review is not the end of the process. You also need to show that participants will receive enough information to make a genuinely informed decision about joining the study. The participant information sheet and informed consent form need to be clear, accurate, written in plain language, and cover both the risks and the potential benefits honestly.
Advertising material
If you are recruiting participants yourself, the ethics committee will want to see how you intend to reach people. Advertising should provide enough information to generate appropriate interest without being misleading about what participation involves. Social media recruitment is now common and perfectly acceptable when handled correctly.
Protocol
Your protocol is the foundational document. It should cover study design, objectives, methodology, statistical analysis plan, and participant selection criteria in detail. Committees need to understand exactly what you intend to do and why.
IMP dossier
If your study involves an investigational medicinal product, you need a comprehensive dossier covering the product, its manufacture, and quality control measures.
Clinical trial agreement (CTA)
The CTA is a legally binding document governing the relationship between the sponsor and the organisation conducting the study. It covers responsibilities, data ownership, publication rights, and financial arrangements. It protects both parties and is required before any site can open.
Data management plan
With most studies now involving digital data collection, being clear about what data will be collected, where it will be stored, who will control it, and how it will be protected is essential. GDPR applies to all studies involving EU or UK participants. Having a named Data Protection Officer and a clear plan before submission avoids questions later.
Site-specific information
Details of the sites involved in the study, whether participants will attend in person, what facilities are available, and what qualifications and certifications the site holds. The committee needs to be confident that the sites are appropriate for the work being done.
The checklist, condensed
| Document | Question it needs to answer |
|---|---|
| Protocol | What exactly will happen, to whom, and why? |
| PIS and consent form | Can a participant genuinely understand what they're agreeing to? |
| Advertising material | Is recruitment honest and not misleading? |
| IMP dossier (if applicable) | Is the product's quality and manufacture documented? |
| Clinical trial agreement | Who is responsible for what, and who owns the data? |
| Data management plan | Where does data live, and who is accountable for protecting it? |
| Site-specific information | Are the sites actually equipped to run this study? |
Getting all of this right before submission saves significant time. Studies that go back and forth through multiple rounds of revisions frequently experience delays that add months to timelines and corresponding increases in cost, well beyond whatever the statutory clock technically allows. A thorough first submission tends to move faster, and given how much of that difference is within a sponsor's own control, it's one of the highest-leverage things a study team can get right before anything is even sent for review.